Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sovcombank finalizes negotiations on the purchase of Absolut Insurance

9/24/24 SVCB

VK launches big data platform

9/24/24 VKCO

Shareholders of TNS Energy Mari El approved dividends

9/23/24 MISB

Petr Ivanov appointed as President of Fesco

9/23/24 FESH

Shareholders of TNS power Rostov-on-Don approved dividends

9/23/24 RTSB

Nornickel may invest in mining projects in Kazakhstan

9/23/24 GMKN

Shareholders of TNS energy Voronezh approved dividends

9/23/24 VRSB

TGC-14 holds SPO

9/23/24 TGKN

Gazprom to maximize supplies through the Power of Siberia ahead of schedule

9/20/24 GAZP

Shareholders of Avangard Bank approved dividends

9/20/24 AVAN